Levilimab
In-game article clicks load inline without leaving the challenge.
Levilimab is an anti-IL-6 monoclonal antibody initially developed to treat rheumatoid arthritis. In 2020, it was approved as a treatment for COVID-19 in Russia.
Fallback article view